M-RCBG Senior Fellow-Led Study Group: Eric Evans
Thursday, March 9, 4:30-6:00, Belfer L-4 Conference Room
The emergence of drug-resistant bacteria is a huge and threatening problem, yet the pharmaceutical and venture capital industries have not stepped forward to address it. Why is that, and what can be done from a public policy point of view? Hear from experts who are on the front lines of antibiotic development.
M-RCBG Senior Fellow Eric Evans will be joined by guest speakers:
M. Kevin Outterson, Executive Director, CARB-X (Combating Antibiotic-Resistant Bacteria)
Martin F. Heidecker, Chief Investment Officer, AMR Action Fund
This study group / discussion is open to all. Registration is not necessary.
M-RCBG welcomes individuals with disabilities to participate in its programs. To request accommodations or ask questions about access provided, please email: firstname.lastname@example.org
Eric Evans is a long-time venture capital investor, executive and entrepreneur, specializing in health care and the life sciences. He currently sits on the Executive Committee of Mass Medical Angels, an investment group that finances early-stage medical technology companies. He is also a Portfolio Executive on the leadership team of RADx (Rapid Acceleration of Diagnostics), a National Institutes of Health initiative to develop COVID diagnostics in a unique public-private partnership. In the past Eric has served as Chief Executive Officer at several early-stage life sciences companies, including Primatope, Pykus, Abazyme, Lumos, Mulleris and Targeted Cell Therapies. He currently serves as Chairman of the Board of Unison Medicines, working to develop a novel antibiotic potentiator. For years previously, he ran Growth Analytics, a boutique strategy consulting firm that counseled senior management of large industrial companies around the world on issues of growth and strategy. He began his consulting career with the Boston Consulting Group, working in the Boston, New York, and Munich offices. Before that, he was in brand management at the Procter & Gamble Company, at world headquarters in Cincinnati, Ohio. He lectures widely (Johns Hopkins University, University of Barcelona, European Institute of Innovation and Technology) on entrepreneurialism, and is the Entrepreneur-in-Residence at the University of Massachusetts. Eric holds a graduate degree in Finance and Public Policy from the Wharton School, University of Pennsylvania and an undergraduate degree in Nuclear Physics from Brown University. As an M-RCBG Senior Fellow, he will be focusing on public-private partnerships in health care. His faculty sponsor is Amitabh Chandra, Ethel Zimmerman Wiener Professor of Public Policy, HKS; Henry and Allison McCance Professor of Business Administration, HBS. Email: email@example.com